@prefix jvr: <http://data.loterre.fr/ark:/67375/JVR> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix mesh: <http://id.nlm.nih.gov/mesh/vocab#> .
@prefix dc: <http://purl.org/dc/terms/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .

jvr:-BT300B3G-Q
  skos:prefLabel "cerebrospinal fluid (Qualifier)"@en, "liquide cérébrospinal (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-VB9HRMXM-N
  mesh:allowableQualifier jvr:-TJHVZCRZ-0, jvr:-S0CS1X5R-5, jvr:-SBNWSM1T-R, jvr:-NKM836P1-M, jvr:-CB30NGKB-3, jvr:-WK5F724J-1, jvr:-FWD2BGQ0-9, jvr:-XV06LPML-W, jvr:-NFTHND7Q-8, jvr:-R0ZCQ8X6-J, jvr:-W6SQV79N-S, jvr:-BT300B3G-Q, jvr:-HQRFT0C6-B, jvr:-R3QWLHRG-V, jvr:-M63HSDM7-1, jvr:-T9HQD7ST-J, jvr:-G4R176S9-J, jvr:-L6C0XPHT-4, jvr:-D0F21513-5, jvr:-H7K65Q8S-Z, jvr:-Q3979798-W, jvr:-NB0XHT3S-N, jvr:-THHNVC7V-3, jvr:-G30ZJ446-J, jvr:-NHL3D2X0-S ;
  mesh:pharmacologicalAction jvr:-RKGZF8PT-H, jvr:-F3DML4KH-4 ;
  skos:hiddenLabel "O-desmethylvenlafaxine"@en, "WY 45233"@en, "WY 45,233"@en, "WY45233"@fr, "Dèsvenlafaxine"@fr, "WY-45233"@fr, "WY-45233"@en, "4-(2-(dimethylamino)-1-(1-hydroxycyclohexyl)ethyl)phenol"@en, "WY-45,233"@en, "Pristiq"@en, "Desvenlafaxine"@en ;
  dc:created "2015-07-09"^^xsd:date ;
  skos:altLabel "NG99554ANW"@fr, "NG99554ANW"@en, "386750-22-7 (desvenlafaxine succinate)"@fr, "386750-22-7 (desvenlafaxine succinate)"@en, "2-(1-hydroxycyclohexyl)-2-((4-hydroxyphenyl)ethyl)dimethylammonium 3-carboxypropanoate monohydrate"@en, "ZB22ENF0XR"@fr, "ZB22ENF0XR"@en, "O-desmethylvenlafaxine Succinate"@en, "O-desmethylvenlafaxine Succinate Monohydrate"@en ;
  skos:broader jvr:-M98PM3T8-K, jvr:-QJHRZ6VR-L ;
  a skos:Concept, mesh:Descriptor ;
  skos:inScheme jvr: ;
  skos:prefLabel "Desvenlafaxine Succinate"@en, "Succinate de dèsvenlafaxine"@fr ;
  skos:definition "A cyclohexanol and phenol derivative and metabolite of venlafaxine that functions as a SEROTONIN AND NORADRENALINE REUPTAKE INHIBITOR (SNRI) and is used as an ANTIDEPRESSIVE AGENT."@en ;
  dc:established "2016-01-01"^^xsd:date ;
  owl:sameAs <http://id.nlm.nih.gov/mesh/D000069468> ;
  dc:modified "2015-07-07"^^xsd:date .

jvr:-L6C0XPHT-4
  skos:prefLabel "métabolisme (Qualificatif)"@fr, "metabolism (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-XV06LPML-W
  skos:prefLabel "urine (Qualifier)"@en, "urine (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-Q3979798-W
  skos:prefLabel "analysis (Qualifier)"@en, "analyse (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-H7K65Q8S-Z
  skos:prefLabel "radiation effects (Qualifier)"@en, "effets des radiations (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-TJHVZCRZ-0
  skos:prefLabel "administration et posologie (Qualificatif)"@fr, "administration & dosage (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-G30ZJ446-J
  skos:prefLabel "toxicity (Qualifier)"@en, "toxicité (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-NFTHND7Q-8
  skos:prefLabel "intoxication (Qualificatif)"@fr, "poisoning (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-FWD2BGQ0-9
  skos:prefLabel "usage thérapeutique (Qualificatif)"@fr, "therapeutic use (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-THHNVC7V-3
  skos:prefLabel "synthèse chimique (Qualificatif)"@fr, "chemical synthesis (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-R0ZCQ8X6-J
  skos:prefLabel "agonistes (Qualificatif)"@fr, "agonists (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-S0CS1X5R-5
  skos:prefLabel "immunology (Qualifier)"@en, "immunologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-QJHRZ6VR-L
  skos:prefLabel "Phenols"@en, "Phénols"@fr ;
  a mesh:Descriptor, skos:Concept ;
  skos:narrower jvr:-VB9HRMXM-N .

jvr:-M63HSDM7-1
  skos:prefLabel "antagonists & inhibitors (Qualifier)"@en, "antagonistes et inhibiteurs (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-HQRFT0C6-B
  skos:prefLabel "isolement et purification (Qualificatif)"@fr, "isolation & purification (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-NB0XHT3S-N
  skos:prefLabel "adverse effects (Qualifier)"@en, "effets indésirables (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-W6SQV79N-S
  skos:prefLabel "classification (Qualifier)"@en, "classification (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-CB30NGKB-3
  skos:prefLabel "economics (Qualifier)"@en, "économie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-G4R176S9-J
  skos:prefLabel "analogs & derivatives (Qualifier)"@en, "analogues et dérivés (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr: a skos:ConceptScheme .
jvr:-M98PM3T8-K
  skos:prefLabel "Cyclohexanols"@fr, "Cyclohexanols"@en ;
  a mesh:Descriptor, skos:Concept ;
  skos:narrower jvr:-VB9HRMXM-N .

jvr:-SBNWSM1T-R
  skos:prefLabel "history (Qualifier)"@en, "histoire (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-D0F21513-5
  skos:prefLabel "chemistry (Qualifier)"@en, "composition chimique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-R3QWLHRG-V
  skos:prefLabel "standards (Qualifier)"@en, "normes (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-NHL3D2X0-S
  skos:prefLabel "sang (Qualificatif)"@fr, "blood (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-T9HQD7ST-J
  skos:prefLabel "ressources et distribution (Qualificatif)"@fr, "supply & distribution (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-RKGZF8PT-H
  skos:prefLabel "Antidépresseurs"@fr, "Antidepressive Agents"@en ;
  a mesh:Descriptor, skos:Concept .

jvr:-NKM836P1-M
  skos:prefLabel "pharmacology (Qualifier)"@en, "pharmacologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-WK5F724J-1
  skos:prefLabel "pharmacokinetics (Qualifier)"@en, "pharmacocinétique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-F3DML4KH-4
  skos:prefLabel "Serotonin and Noradrenaline Reuptake Inhibitors"@en, "Inhibiteurs de la recapture de la sérotonine et de la noradrénaline"@fr ;
  a mesh:Descriptor, skos:Concept .